Can Coronary Artery Involvement in Kawasaki Disease be Predicted?

by Ghelani, Sunil J., Kwatra, Neha S., Spurney, Christopher F.
Published 2013

Membrane Sealant Poloxamer P188 Protects Against Isoproterenol Induced Cardiomyopathy in Dystrophin Deficient Mice

by Spurney, Christopher F, Guerron, Alfredo D, Yu, Qing, Sali, Arpana, van der Meulen, Jack H, Hoffman, Eric P, Nagaraju, Kanneboyina
Published 2011

Glucocorticoid-Treated Mice Are an Inappropriate Positive Control for Long-Term Preclinical Studies in the mdx Mouse

by Sali, Arpana, Guerron, Alfredo D., Gordish-Dressman, Heather, Spurney, Christopher F., Iantorno, Micaela, Hoffman, Eric P., Nagaraju, Kanneboyina
Published 2012

Native T1 values identify myocardial changes and stratify disease severity in patients with Duchenne muscular dystrophy

by Olivieri, Laura J., Kellman, Peter, McCarter, Robert J., Cross, Russell R., Hansen, Michael S., Spurney, Christopher F.
Published 2016

Omigapil Treatment Decreases Fibrosis and Improves Respiratory Rate in dy2J Mouse Model of Congenital Muscular Dystrophy

by Yu, Qing, Sali, Arpana, Van der Meulen, Jack, Creeden, Brittany K., Gordish-Dressman, Heather, Rutkowski, Anne, Rayavarapu, Sree, Uaesoontrachoon, Kitipong, Huynh, Tony, Nagaraju, Kanneboyina, Spurney, Christopher F.
Published 2013

The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice

by Sali, Arpana, Many, Gina M., Gordish-Dressman, Heather, van der Meulen, Jack H., Phadke, Aditi, Spurney, Christopher F., Cnaan, Avital, Hoffman, Eric P., Nagaraju, Kanneboyina
Published 2013